Solasia Pharma is an oncology-focused specialty pharmaceutical company engaged in the development and commercialization of innovative medicines for cancer treatment and management of cancer therapy-related side effects across Japan and Asian markets including China and South Korea. The company in-licenses drug and medical device candidates at various clinical stages, conducts clinical development primarily in Japan and Asia, and generates revenue through product sales, out-licensing, milestones, and royalties. Its current marketed products include Darbias (SP-02) for peripheral T-cell lymphoma in Japan and Episil (SP-03), a medical device for oral mucositis pain relief, approved in Japan, China, and South Korea.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →Solasia Pharma is an oncology-focused specialty pharmaceutical company engaged in the development and commercialization of innovative medicines for cancer treatment and management of cancer therapy-related side effects across Japan and Asian markets including China and South Korea. The company in-licenses drug and medical device candidates at various clinical stages, conducts clinical development primarily in Japan and Asia, and generates revenue through product sales, out-licensing, milestones, and royalties. Its current marketed products include Darbias (SP-02) for peripheral T-cell lymphoma in Japan and Episil (SP-03), a medical device for oral mucositis pain relief, approved in Japan, China, and South Korea.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →